Cyclooxygenase-3: a new target for pain management?

MI Wen-li,WANG Yan-qing,WU Gen-cheng
DOI: https://doi.org/10.3969/j.issn.1673-2588.2006.05.017
2006-01-01
Abstract:Cyclooxygenases(COX),target of nonsteroidal anti-inflammatory drugs(NSAIDs),convert arachidonic acid released by membrane phospholipids into prostaglandins.COX-3,a new member of the COX family,has various structure,distribution and activity in different species such as dog,human,rat and mouse.Although there are still disputes about the function of COX-3,its possible roles in the development of pain and analgesia have been concentrated.Further study on COX-3 would possibly provide a new target for clinical pain management.
What problem does this paper attempt to address?